PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.\', \'Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.\', \'Health Sciences University Hamidiye International Medical School, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey.\', \'Health Science University Turkey, Ankara City Hospital, 06800, Ankara, Turkey.\', \'Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul University, Fatih, 34093, Istanbul, Turkey.\', \'Faculty of Medicine, Hacettepe University, Ankara, Turkey.\', \'Health Science University Turkey, Umraniye Training and Research Hospital, Istanbul, Turkey.\', \'Faculty of Medicine, Marmara University, Istanbul, Turkey.\', \'Health Science University Turkey, Bakırköy Sadi Konuk Education and Training Hospital, Istanbul, Turkey.\', \'Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.\', \'Yıldırım Bayazıt University, Ankara City Hospital, 06800, Ankara, Turkey.\', \'Health Science University Turkey, Prof. Dr. Cemil Taşcıoğlu City Hospital, İstanbul, Turkey.\', \'Acibadem Bakirkoy Hospital, Istanbul, Turkey.\', \'Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul University, Fatih, 34093, Istanbul, Turkey. agul@istanbul.edu.tr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00296-021-04965-6
?:doi
?:hasPublicationType
?:journal
  • Rheumatology international
is ?:pmid of
?:pmid
?:pmid
  • 34515808
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.906
?:rankingScore_hIndex
  • 62
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all